Literature DB >> 24728310

Percutaneous grafting with bone marrow autologous concentrate for open tibia fractures: analysis of forty three cases and literature review.

Louis-Romée Le Nail1, Julien Stanovici, Joseph Fournier, Marie Splingard, Jorge Domenech, Philippe Rosset.   

Abstract

PURPOSE: Tibial fractures are the most common lower limb fractures. Some criteria such as open fractures and increasing open stage are known to be associated with high delayed union and pseudarthrosis rate. In cases of delayed or nonunion, classical treatment is autologous cancelous bone graft which is associated with high morbidity rate. The ideal treatment would be a percutaneous harvesting and grafting technique. As bone marrow autologous concentrate (BMAC) presents both advantages, we evaluated this technique from 2002 to 2007.
METHODS: This was a retrospective study of 43 cases of open tibial fractures with initial surgical treatment. The criteria of inclusion were open fracture and nonunion, delayed union or suspicion of delayed union.
RESULTS: In 23 cases (53.5 %) BMAC was successful. The success group had received significantly more CFU-F than the failure group (469 vs 153.10(3), p = 0.013). A threshold of 360.10(3) CFU-F grafted could be established over which there was 100 % success. BMAC done before 110 days after fracture had 47 % success and BMAC done since 110 days after fracture had 73 % success. BMAC success rate decreased with increasing initial fracture skin open stage. There was no BMAC success in cases of a fracture with a remaining gap of more than 4 mm. We had no complications with the technique at the iliac harvesting zone and tibia injection point.
CONCLUSION: BMAC is a technique that should be considered as one of the different alternatives for management of long-bone delayed and nonunion because of its effectiveness, low complication rate, preservation of bone stock and low cost.

Entities:  

Mesh:

Year:  2014        PMID: 24728310     DOI: 10.1007/s00264-014-2342-x

Source DB:  PubMed          Journal:  Int Orthop        ISSN: 0341-2695            Impact factor:   3.075


  58 in total

1.  Percutaneous autologous bone-marrow grafting for nonunions. Influence of the number and concentration of progenitor cells.

Authors:  Ph Hernigou; A Poignard; F Beaujean; H Rouard
Journal:  J Bone Joint Surg Am       Date:  2005-07       Impact factor: 5.284

2.  Delayed unions of the tibia.

Authors:  Laura S Phieffer; James A Goulet
Journal:  J Bone Joint Surg Am       Date:  2006-01       Impact factor: 5.284

Review 3.  Injectable bone marrow preparations to stimulate osteogenic repair.

Authors:  J F Connolly
Journal:  Clin Orthop Relat Res       Date:  1995-04       Impact factor: 4.176

4.  Cancer risk is not increased in patients treated for orthopaedic diseases with autologous bone marrow cell concentrate.

Authors:  Philippe Hernigou; Yasuhiro Homma; Charles-Henri Flouzat-Lachaniette; Alexandre Poignard; Nathalie Chevallier; Helene Rouard
Journal:  J Bone Joint Surg Am       Date:  2013-12-18       Impact factor: 5.284

5.  Natural history of posterior iliac crest bone graft donation for spinal surgery: a prospective analysis of morbidity.

Authors:  P A Robertson; A C Wray
Journal:  Spine (Phila Pa 1976)       Date:  2001-07-01       Impact factor: 3.468

Review 6.  The economics of treating tibia fractures. The cost of delayed unions.

Authors:  J D Heckman; J Sarasohn-Kahn
Journal:  Bull Hosp Jt Dis       Date:  1997

7.  Age- and gender-related changes in the cellularity of human bone marrow and the prevalence of osteoblastic progenitors.

Authors:  G F Muschler; H Nitto; C A Boehm; K A Easley
Journal:  J Orthop Res       Date:  2001-01       Impact factor: 3.494

Review 8.  The biology of platelet-rich plasma and its application in trauma and orthopaedic surgery: a review of the literature.

Authors:  J Alsousou; M Thompson; P Hulley; A Noble; K Willett
Journal:  J Bone Joint Surg Br       Date:  2009-08

9.  Percutaneous bone marrow grafting of delayed union and nonunion in cancer patients.

Authors:  J H Healey; P A Zimmerman; J M McDonnell; J M Lane
Journal:  Clin Orthop Relat Res       Date:  1990-07       Impact factor: 4.176

10.  Prospective study of iliac crest bone graft harvest site pain and morbidity.

Authors:  David H Kim; Richard Rhim; Ling Li; Juli Martha; Bryan H Swaim; Robert J Banco; Louis G Jenis; Scott G Tromanhauser
Journal:  Spine J       Date:  2009-06-18       Impact factor: 4.166

View more
  15 in total

Review 1.  Mechanistic role of perfusion culture on bone regeneration.

Authors:  Bhaskar Birru; Naveen Kumar Mekala; Sreenivasa Rao Parcha
Journal:  J Biosci       Date:  2019-03       Impact factor: 1.826

2.  Local transplantation of bone marrow concentrated granulocytes precursors can cure without antibiotics infected nonunion of polytraumatic patients in absence of bone defect.

Authors:  Philippe Hernigou; Matthieu Trousselier; François Roubineau; Charlie Bouthors; Nathalie Chevallier; Helene Rouard; Charles Henri Flouzat-Lachaniette
Journal:  Int Orthop       Date:  2016-03-01       Impact factor: 3.075

3.  Tissue engineering and regenerative orthopaedics (TERO).

Authors:  Marko Pećina; Slobodan Vukičević
Journal:  Int Orthop       Date:  2014-08-12       Impact factor: 3.075

4.  Percutaneous injection of bone marrow mesenchymal stem cells for ankle non-unions decreases complications in patients with diabetes.

Authors:  Philippe Hernigou; Isaac Guissou; Yasuhiro Homma; Alexandre Poignard; Nathalie Chevallier; Helene Rouard; Charles Henri Flouzat Lachaniette
Journal:  Int Orthop       Date:  2015-03-22       Impact factor: 3.075

5.  Osteogenic progenitors in bone marrow aspirates have clinical potential for tibial non-unions healing in diabetic patients.

Authors:  Charles Henri Flouzat-Lachaniette; Clemence Heyberger; Charlie Bouthors; François Roubineau; Nathalie Chevallier; Helene Rouard; Philippe Hernigou
Journal:  Int Orthop       Date:  2015-11-17       Impact factor: 3.075

6.  Ilizarov bone transport combined with antibiotic cement spacer for infected tibial nonunion.

Authors:  Jing Peng; Li Min; Zhou Xiang; Fuguo Huang; Chongqi Tu; Hui Zhang
Journal:  Int J Clin Exp Med       Date:  2015-06-15

Review 7.  Bone marrow derived stem cells in joint and bone diseases: a concise review.

Authors:  Antonio Marmotti; Laura de Girolamo; Davide Edoardo Bonasia; Matteo Bruzzone; Silvia Mattia; Roberto Rossi; Angela Montaruli; Federico Dettoni; Filippo Castoldi; Giuseppe Peretti
Journal:  Int Orthop       Date:  2014-07-09       Impact factor: 3.075

8.  Human autologous mesenchymal stem cells with extracorporeal shock wave therapy for nonunion of long bones.

Authors:  Lei Zhai; Xin-Long Ma; Chuan Jiang; Bo Zhang; Shui-Tao Liu; Geng-Yan Xing
Journal:  Indian J Orthop       Date:  2016-09       Impact factor: 1.251

Review 9.  The Components of Bone and What They Can Teach Us about Regeneration.

Authors:  Bach Quang Le; Victor Nurcombe; Simon McKenzie Cool; Clemens A van Blitterswijk; Jan de Boer; Vanessa Lydia Simone LaPointe
Journal:  Materials (Basel)       Date:  2017-12-22       Impact factor: 3.623

10.  Percutaneous autologous bone marrow transplantation for the treatment of delayed union of limb bone in children.

Authors:  Jun Wu; Hongxi Guo; Xing Liu; Ming Li; Yujiang Cao; Xiangyang Qu; Hai Zhou; Liuqi Weng
Journal:  Ther Clin Risk Manag       Date:  2018-02-02       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.